Foresite Capital Management III, LLC - VERONA PHARMA PLC ownership

VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 9 filers reported holding VERONA PHARMA PLC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
Foresite Capital Management III, LLC ownership history of VERONA PHARMA PLC
ValueSharesWeighting
Q3 2022$11,356,000
+143.9%
1,111,1120.0%29.98%
+77.5%
Q2 2022$4,656,000
-16.0%
1,111,1120.0%16.89%
-0.0%
Q1 2022$5,544,000
-25.8%
1,111,1120.0%16.90%
-10.6%
Q4 2021$7,467,000
+22.6%
1,111,1120.0%18.90%
+123.9%
Q3 2021$6,089,000
-16.2%
1,111,1120.0%8.44%
+9.6%
Q2 2021$7,267,000
-21.8%
1,111,1120.0%7.70%
-5.6%
Q1 2021$9,289,000
+34.0%
1,111,1120.0%8.16%
+58.0%
Q3 2020$6,933,000
+247.7%
1,111,112
+437.6%
5.16%
+688.1%
Q4 2018$1,994,000
-68.2%
206,663
-58.7%
0.66%
-52.6%
Q3 2018$6,266,000
-8.8%
500,883
-0.4%
1.38%
-6.5%
Q2 2018$6,869,000
-39.2%
502,825
-11.1%
1.48%
-40.0%
Q1 2018$11,306,000
+80.2%
565,292
+7.0%
2.46%
+40.0%
Q4 2017$6,273,000
-32.9%
528,422
-13.2%
1.76%
-31.6%
Q3 2017$9,346,000
+30.7%
608,851
-0.8%
2.57%
+10.2%
Q2 2017$7,152,000613,6012.34%
Other shareholders
VERONA PHARMA PLC shareholders Q2 2017
NameSharesValueWeighting ↓
Vivo Capital, LLC 4,249,918$69,273,6637.59%
Aisling Capital Management LP 1,115,352$18,180,2387.49%
NEA Management Company, LLC 5,108,563$91,031,4747.03%
Octagon Capital Advisors LP 2,369,000$38,614,7005.93%
Knoll Capital Management, LLC 200,000$3,260,0003.38%
Frazier Life Sciences Management, L.P. 3,014,349$49,133,8893.26%
Perceptive Advisors 4,007,197$65,317,3112.18%
RA Capital Management 6,317,990$102,983,2372.03%
Deep Track Capital, LP 3,187,415$51,954,8652.00%
Carlyle Group Inc. 2,457,500$40,008,1001.74%
View complete list of VERONA PHARMA PLC shareholders